Skip to main content

NAV · NAVCO Pharmaceuticals Inc. · Documents

0.0050 CAD +0.0000 (+0.00%) At close · Oct 28 Intraday price with Plus
Market Cap
285,347 CAD
Shares
57.07M

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

2020
Feb 19
Report SEDAR+
MD&A
2019
Nov 14
Report SEDAR+
MD&A
Oct 17
Report SEDAR+
MD&A
May 30
Report SEDAR+
MD&A
Feb 28
Report SEDAR+
MD&A
2018
Nov 21
Report SEDAR+
MD&A
Sep 28
Offering documents SEDAR+
6 offering documents
  • Final prospectus 1
  • Underwriting or agency agreement 1
  • Consent letter(s) of issuer's legal counsel 1
  • Auditors' consent letter 1
  • Other offering documents 2
Aug 13
Offering documents SEDAR+
3 offering documents
  • Securities Offerings 1
  • Preliminary prospectus 1
  • Decision Document (Preliminary) 1
Showing 201–239 of 239 documents